These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 25015340)

  • 1. Prognostic value of fasting versus nonfasting low-density lipoprotein cholesterol levels on long-term mortality: insight from the National Health and Nutrition Examination Survey III (NHANES-III).
    Doran B; Guo Y; Xu J; Weintraub H; Mora S; Maron DJ; Bangalore S
    Circulation; 2014 Aug; 130(7):546-53. PubMed ID: 25015340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reply to Letters Regarding Article, "Prognostic Value of Fasting Versus Nonfasting Low-Density Lipoprotein Cholesterol Levels on Long-Term Mortality: Insight From the National Health and Nutrition Examination Survey III (NHANES-III)".
    Doran B; Guo Y; Xu J; Weintraub H; Mora S; Maron DJ; Bangalore S
    Circulation; 2015 May; 131(19):e473. PubMed ID: 25964286
    [No Abstract]   [Full Text] [Related]  

  • 3. Letter by Aldasouqi and Abela Regarding Article, "Prognostic Value of Fasting Versus Nonfasting Low-Density Lipoprotein Cholesterol Levels on Long-Term Mortality: Insight From the National Health and Nutrition Survey III (NHANES-III)".
    Aldasouqi S; Abela G
    Circulation; 2015 May; 131(19):e471. PubMed ID: 25964284
    [No Abstract]   [Full Text] [Related]  

  • 4. Letter by Horne et al Regarding Article, "Prognostic Value of Fasting Versus Nonfasting Low-Density Lipoprotein Cholesterol Levels on Long-Term Mortality: Insight From the National Health and Nutrition Survey III (NHANES-III)".
    Horne BD; Muhlestein JB; Anderson JL
    Circulation; 2015 May; 131(19):e472. PubMed ID: 25964285
    [No Abstract]   [Full Text] [Related]  

  • 5. Fasting and nonfasting lipid levels: influence of normal food intake on lipids, lipoproteins, apolipoproteins, and cardiovascular risk prediction.
    Langsted A; Freiberg JJ; Nordestgaard BG
    Circulation; 2008 Nov; 118(20):2047-56. PubMed ID: 18955664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between nonfasting and fasting lipid measurements in patients with or without type 2 diabetes mellitus receiving treatment with 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors.
    Weiss R; Harder M; Rowe J
    Clin Ther; 2003 May; 25(5):1490-7. PubMed ID: 12867223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fasting Versus Nonfasting and Low-Density Lipoprotein Cholesterol Accuracy.
    Sathiyakumar V; Park J; Golozar A; Lazo M; Quispe R; Guallar E; Blumenthal RS; Jones SR; Martin SS
    Circulation; 2018 Jan; 137(1):10-19. PubMed ID: 29038168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of cardiovascular mortality in relation to optimal low-density lipoprotein cholesterol combined with hypertriglyceridemia: is there a difference by gender?
    Kuklina EV; Keenan NL; Callaghan WM; Hong Y
    Ann Epidemiol; 2011 Nov; 21(11):807-14. PubMed ID: 21982483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fasting compared with nonfasting lipids and apolipoproteins for predicting incident cardiovascular events.
    Mora S; Rifai N; Buring JE; Ridker PM
    Circulation; 2008 Sep; 118(10):993-1001. PubMed ID: 18711012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum phosphorus and mortality in the Third National Health and Nutrition Examination Survey (NHANES III): effect modification by fasting.
    Chang AR; Grams ME
    Am J Kidney Dis; 2014 Oct; 64(4):567-73. PubMed ID: 24935232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of low low-density lipoprotein cholesterol with elevated high sensitivity C-reactive protein in the U.S.: implications of the JUPITER (Justification for the Use of Statins in Primary Prevention: An Intervention Trial Evaluating Rosuvastatin) study.
    Michos ED; Blumenthal RS
    J Am Coll Cardiol; 2009 Mar; 53(11):931-5. PubMed ID: 19281922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibodies to malondialdehyde oxidized low-density lipoproteins predict long term cardiovascular mortality in high risk patients.
    Maiolino G; Pedon L; Cesari M; Frigo AC; Barisa M; Rossitto G; Seccia TM; Zanchetta M; Rossi GP
    Int J Cardiol; 2013 Sep; 168(1):484-9. PubMed ID: 23102599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gender differences in cardiovascular mortality by C-reactive protein level in the United States: evidence from the National Health and Nutrition Examination Survey III.
    Doran B; Zhu W; Muennig P
    Am Heart J; 2013 Jul; 166(1):45-51. PubMed ID: 23816020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonfasting versus fasting lipid profile for cardiovascular risk prediction.
    Langsted A; Nordestgaard BG
    Pathology; 2019 Feb; 51(2):131-141. PubMed ID: 30522787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of lipid abnormalities in the United States: the National Health and Nutrition Examination Survey 2003-2006.
    Tóth PP; Potter D; Ming EE
    J Clin Lipidol; 2012; 6(4):325-30. PubMed ID: 22836069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated remnant cholesterol causes both low-grade inflammation and ischemic heart disease, whereas elevated low-density lipoprotein cholesterol causes ischemic heart disease without inflammation.
    Varbo A; Benn M; Tybjærg-Hansen A; Nordestgaard BG
    Circulation; 2013 Sep; 128(12):1298-309. PubMed ID: 23926208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Fasting and nonfasting lipids--secondary publication].
    Langsted A; Freiberg JJ; Nordestgaard BG
    Ugeskr Laeger; 2009 Jun; 171(26):2184-7. PubMed ID: 19678434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of triglyceride-rich lipoproteins-related markers and low-density lipoprotein heterogeneity with cardiovascular risk: effectiveness of polyacrylamide-gel electrophoresis as a method of determining low-density lipoprotein particle size.
    Tani S; Matsumoto M; Nagao K; Hirayama A
    J Cardiol; 2014 Jan; 63(1):60-8. PubMed ID: 24016623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive value of remnant lipoprotein for cardiovascular events in patients with coronary artery disease after achievement of LDL-cholesterol goals.
    Nakamura T; Obata JE; Hirano M; Kitta Y; Fujioka D; Saito Y; Kawabata K; Watanabe K; Watanabe Y; Mishina H; Kugiyama K
    Atherosclerosis; 2011 Sep; 218(1):163-7. PubMed ID: 21605862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of fasting and nonfasting serum triglycerides with cardiovascular disease and the role of remnant-like lipoproteins and small dense LDL.
    Stalenhoef AF; de Graaf J
    Curr Opin Lipidol; 2008 Aug; 19(4):355-61. PubMed ID: 18607182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.